| Year |
Citation |
Score |
| 2017 |
Beaudry H, Daou I, Ribeiro-da-Silva A, Séguéla P. Will optogenetics be used to treat chronic pain patients? Pain Management. PMID 28726577 DOI: 10.2217/Pmt-2016-0055 |
0.587 |
|
| 2017 |
Beaudry H, Daou I, Ase AR, Ribeiro-da-Silva A, Séguéla P. Distinct behavioral responses evoked by selective optogenetic stimulation of the major TRPV1+ and MrgD+ subsets of C-fibers. Pain. PMID 28708765 DOI: 10.1097/J.Pain.0000000000001016 |
0.566 |
|
| 2016 |
Daou I, Beaudry H, Ase AR, Wieskopf JS, Ribeiro-da-Silva A, Mogil JS, Séguéla P. Optogenetic Silencing of Nav1.8-Positive Afferents Alleviates Inflammatory and Neuropathic Pain. Eneuro. 3. PMID 27022626 DOI: 10.1523/ENEURO.0140-15.2016 |
0.607 |
|
| 2016 |
Beaudry H, Daou I, Ribeiro-da-Silva A, Séguéla P. Optogénétique et douleur chronique : une stratégie applicable chez l’humain ? Douleur Et AnalgéSie. 29: 232-240. DOI: 10.1007/S11724-016-0477-9 |
0.441 |
|
| 2015 |
Beaudry H, Gendron L, Morón JA. Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain. The European Journal of Neuroscience. 41: 901--7. PMID 25639561 DOI: 10.1111/Ejn.12829 |
0.69 |
|
| 2015 |
Beaudry H, Mercier-Blais AA, Delaygue C, Lavoie C, Parent JL, Neugebauer W, Gendron L. Regulation of μ and δ opioid receptor functions: involvement of cyclin-dependent kinase 5. British Journal of Pharmacology. 172: 2573-87. PMID 25598508 DOI: 10.1111/bph.13088 |
0.662 |
|
| 2015 |
Gendron L, Mittal N, Beaudry H, Walwyn W. Recent advances on the δ opioid receptor: from trafficking to function. British Journal of Pharmacology. 172: 403-19. PMID 24665909 DOI: 10.1111/Bph.12706 |
0.64 |
|
| 2015 |
Beaudry H, Ribeiro-Da-Silva A, Seguela P. (353) A direct role of the sympathetic nervous system in chronic pain? An optogenetic approach The Journal of Pain. 16: S64. DOI: 10.1016/J.Jpain.2015.01.271 |
0.571 |
|
| 2013 |
Cabañero D, Baker A, Zhou S, Hargett GL, Irie T, Xia Y, Beaudry H, Gendron L, Melyan Z, Carlton SM, Morón JA. Pain after discontinuation of morphine treatment is associated with synaptic increase of GluA4-containing AMPAR in the dorsal horn of the spinal cord. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1472-84. PMID 23403695 DOI: 10.1038/Npp.2013.46 |
0.674 |
|
| 2012 |
Parent AJ, Beaudet N, Beaudry H, Bergeron J, Bérubé P, Drolet G, Sarret P, Gendron L. Increased anxiety-like behaviors in rats experiencing chronic inflammatory pain. Behavioural Brain Research. 229: 160-7. PMID 22245257 DOI: 10.1016/J.Bbr.2012.01.001 |
0.628 |
|
| 2011 |
Beaudry H, Dubois D, Gendron L. Activation of spinal mu- and delta-opioid receptors potently inhibits substance P release induced by peripheral noxious stimuli. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 13068-77. PMID 21917790 DOI: 10.1523/Jneurosci.1817-11.2011 |
0.716 |
|
| 2010 |
Roussy G, Beaudry H, Lafrance M, Belleville K, Beaudet N, Wada K, Gendron L, Sarret P. Altered morphine-induced analgesia in neurotensin type 1 receptor null mice. Neuroscience. 170: 1286-94. PMID 20727387 DOI: 10.1016/J.Neuroscience.2010.08.016 |
0.703 |
|
| 2009 |
Beaudry H, Proteau-Gagné A, Li S, Dory Y, Chavkin C, Gendron L. Differential noxious and motor tolerance of chronic delta opioid receptor agonists in rodents. Neuroscience. 161: 381-91. PMID 19328839 DOI: 10.1016/J.Neuroscience.2009.03.053 |
0.692 |
|
| 2008 |
Wallinder C, Botros M, Rosenström U, Guimond MO, Beaudry H, Nyberg F, Gallo-Payet N, Hallberg A, Alterman M. Selective angiotensin II AT2 receptor agonists: Benzamide structure-activity relationships. Bioorganic & Medicinal Chemistry. 16: 6841-9. PMID 18599297 DOI: 10.1016/J.Bmc.2008.05.066 |
0.388 |
|
| 2008 |
Wallinder C, Botros M, Rosenström U, Guimond M, Beaudry H, Nyberg F, Gallo-Payet N, Hallberg A, Alterman M. Erratum to “Selective angiotensin II AT2 receptor agonists: Benzamide structure–activity relationships” [Bioorg. Med. Chem. 16 (2008) 6841–6849] Bioorganic & Medicinal Chemistry. 16: 8765. DOI: 10.1016/J.Bmc.2008.08.045 |
0.355 |
|
| 2006 |
Plouffe B, Guimond MO, Beaudry H, Gallo-Payet N. Role of tyrosine kinase receptors in angiotensin II AT2 receptor signaling: involvement in neurite outgrowth and in p42/p44mapk activation in NG108-15 cells. Endocrinology. 147: 4646-54. PMID 16809450 DOI: 10.1210/En.2005-1315 |
0.379 |
|
| 2006 |
Georgsson J, Rosenström U, Wallinder C, Beaudry H, Plouffe B, Lindeberg G, Botros M, Nyberg F, Karlén A, Gallo-Payet N, Hallberg A. Short pseudopeptides containing turn scaffolds with high AT2 receptor affinity. Bioorganic & Medicinal Chemistry. 14: 5963-72. PMID 16753301 DOI: 10.1016/J.Bmc.2006.05.019 |
0.332 |
|
| 2006 |
Beaudry H, Gendron L, Guimond MO, Payet MD, Gallo-Payet N. Involvement of protein kinase C alpha (PKC alpha) in the early action of angiotensin II type 2 (AT2) effects on neurite outgrowth in NG108-15 cells: AT2-receptor inhibits PKC alpha and p21ras activity. Endocrinology. 147: 4263-72. PMID 16740968 DOI: 10.1210/En.2006-0411 |
0.584 |
|
| 2005 |
Rosenström U, Sköld C, Plouffe B, Beaudry H, Lindeberg G, Botros M, Nyberg F, Wolf G, Karlén A, Gallo-Payet N, Hallberg A. New selective AT2 receptor ligands encompassing a gamma-turn mimetic replacing the amino acid residues 4-5 of angiotensin II act as agonists. Journal of Medicinal Chemistry. 48: 4009-24. PMID 15943474 DOI: 10.1021/Jm0491492 |
0.388 |
|
| 2004 |
Wan Y, Wallinder C, Plouffe B, Beaudry H, Mahalingam AK, Wu X, Johansson B, Holm M, Botoros M, Karlén A, Pettersson A, Nyberg F, Fändriks L, Gallo-Payet N, Hallberg A, et al. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. Journal of Medicinal Chemistry. 47: 5995-6008. PMID 15537354 DOI: 10.1021/Jm049715T |
0.402 |
|
| Show low-probability matches. |